BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for Forte Biosciences, Inc. (FBRX)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Forte Biosciences, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-08-10
4:34 pm
Purchase		 2023-07-31 13G Forte Biosciences, Inc.
FBRX		 BIOTECHNOLOGY VALUE FUND L P 119,284
8.200%		 119,284increase
(New Position)		 Filing
2022-02-11
7:41 pm
Sale		 2021-12-31 13G Forte Biosciences, Inc.
FBRX		 BIOTECHNOLOGY VALUE FUND L P 0
0.000%		 -53,770decrease
(Position Closed)		 Filing
2021-02-12
4:11 pm
Purchase		 2020-12-31 13G Forte Biosciences, Inc.
FBRX		 BIOTECHNOLOGY VALUE FUND L P 53,770
9.990%		 10,171increase
(+23.33%)		 Filing
2020-06-25
5:13 pm
Purchase		 2020-06-15 13G Forte Biosciences, Inc.
FBRX		 BIOTECHNOLOGY VALUE FUND L P 43,599
9.990%		 43,599increase
(New Position)		 Filing